These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21371303)

  • 1. Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.
    Arnold DT; Bentham LM; Jacob RP; Lilford RJ; Girling AJ
    BMC Fam Pract; 2011 Mar; 12():9. PubMed ID: 21371303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study.
    Lilford RJ; Bentham L; Girling A; Litchfield I; Lancashire R; Armstrong D; Jones R; Marteau T; Neuberger J; Gill P; Cramb R; Olliff S; Arnold D; Khan K; Armstrong MJ; Houlihan DD; Newsome PN; Chilton PJ; Moons K; Altman D
    Health Technol Assess; 2013 Jul; 17(28):i-xiv, 1-307. PubMed ID: 23834998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of liver dysfunction: who should we test for hepatitis E?
    Wallace SJ; Webb GW; Madden RG; Dalton HC; Palmer J; Dalton RT; Pollard A; Martin R; Panayi V; Bennett G; Bendall RP; Dalton HR
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):215-220. PubMed ID: 27832041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care.
    Dillon JF; Miller MH; Robinson EM; Hapca A; Rezaeihemami M; Weatherburn C; McIntyre PG; Bartlett B; Donnan PT; Boyd KA; Dow E
    J Hepatol; 2019 Oct; 71(4):699-706. PubMed ID: 31226388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting.
    Heidrich B; Cetindere A; Beyaz M; Stahmeyer JT; Basaran MM; Braynis B; Raupach R; Bremer B; Manns MP; Wedemeyer H; Bastürk M
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1090-7. PubMed ID: 25076065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of mild alanine aminotransferase elevation identifies hidden hepatitis C in primary care.
    Helsper C; van Essen G; Frijling BD; de Wit NJ
    Br J Gen Pract; 2012 Mar; 62(596):e212-6. PubMed ID: 22429439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERIAL CHANGES OF LIVER FUNCTION TESTS BEFORE AND DURING METHIMAZOLE TREATMENT IN THYROTOXIC PATIENTS.
    Niculescu DA; Dusceac R; Galoiu SA; Capatina CA; Poiana C
    Endocr Pract; 2016 Aug; 22(8):974-9. PubMed ID: 27042749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection: an AIGO study.
    Andriulli A; Festa V; Leandro G; Rizzetto M
    Dig Dis Sci; 2001 Jul; 46(7):1409-15. PubMed ID: 11478491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
    Xie Y; Yi W; Zhang L; Lu Y; Hao HX; Gao YJ; Ran CP; Lu HH; Chen QQ; Shen G; Wu SL; Chang M; Ping-Hu L; Liu RY; Sun L; Wan G; Li MH
    J Viral Hepat; 2019 Jul; 26 Suppl 1():42-49. PubMed ID: 31380591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.
    Sterling RK; Brown RS; Hofmann CM; Luketic VA; Stravitz RT; Sanyal AJ; Contos MJ; Mills AS; Smith V; Shiffman ML
    Am J Gastroenterol; 2005 Feb; 100(2):313-21. PubMed ID: 15667488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budget impact analysis on the introduction of a guideline based hepatitis B and C screening into a routine check-up in the German primary care setting.
    Barth C; Neusser S; Biermann J; Wasem J; Berg T; Wiegand J; Wolffram I; Petroff D; Aidelsburger P; Grünbauer A; Neumann A
    Scand J Gastroenterol; 2018 Jan; 53(1):76-82. PubMed ID: 29065740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
    Lee MH; Kim YM; Kim SG
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.
    Schwimmer JB; Dunn W; Norman GJ; Pardee PE; Middleton MS; Kerkar N; Sirlin CB
    Gastroenterology; 2010 Apr; 138(4):1357-64, 1364.e1-2. PubMed ID: 20064512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
    Cheong JY; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Cho SW
    Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health outcomes following liver function testing in primary care: a retrospective cohort study.
    McLernon DJ; Donnan PT; Ryder S; Roderick P; Sullivan FM; Rosenberg W; Dillon JF
    Fam Pract; 2009 Aug; 26(4):251-9. PubMed ID: 19439435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE).
    Donnan PT; McLernon D; Dillon JF; Ryder S; Roderick P; Sullivan F; Rosenberg W
    Health Technol Assess; 2009 Apr; 13(25):iii-iv, ix-xi, 1-134. PubMed ID: 19413926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT.
    Wang CC; Lim LY; Deubner H; Tapia K; Lau AW; Manansala J; Krows M; Shuhart MC; Kowdley KV
    J Clin Gastroenterol; 2008 Aug; 42(7):820-6. PubMed ID: 18458642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive testing or focused testing of patients with elevated liver enzymes.
    Tapper EB; Saini SD; Sengupta N
    J Hepatol; 2017 Feb; 66(2):313-319. PubMed ID: 27717864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.